| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/15/2011 | CN102093982A H9N2 subtype avian influenza virus strain and application thereof |
| 06/15/2011 | CN102093479A Recombinant chimeric antibody of anti-human vascular endothelium growth factor receptor 2 |
| 06/15/2011 | CN102093478A Preparation and application of antithyroidin (T4) monoclonal antibody |
| 06/15/2011 | CN102093477A Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same |
| 06/15/2011 | CN101608182B Oncogene, recombinant protein derived therefrom, and uses thereof |
| 06/15/2011 | CN101302254B Monoclonal antibody of hepatoma-derived growth factor and use thereof |
| 06/15/2011 | CN101235086B Recombination human rabies viruses resisting antibody |
| 06/14/2011 | US7960527 Nucleic acid and corresponding protein entitled 151P3D4 useful in treatment and detection of cancer |
| 06/14/2011 | US7960518 Human binding molecules having killing activity against enterococci and uses thereof |
| 06/14/2011 | US7960516 Solid forms of anti-EGFR antibodies |
| 06/14/2011 | US7960515 Binding molecules to the human OX40 receptor |
| 06/14/2011 | US7960514 IL-7 fusion proteins |
| 06/14/2011 | US7960513 Antibody against a human ADAM protease |
| 06/14/2011 | US7960512 Identification and engineering of antibodies with variant Fc regions and methods of using same |
| 06/14/2011 | US7960508 A peptide fragment containing selenocysteine has a lowered toxicity than selenocystine, exhibits a cytotoxicity-inhibitory activity; screening a drug having cytotoxicity-inhibitory activity by utilizing a cellular sudden death phenomenon in a cell culture system; glutathione peroxidase activity |
| 06/14/2011 | US7960507 Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| 06/14/2011 | US7960361 Formulating an anti-cancer vaccine comprising an agent that can stimulate an immune response against IL-13R alpha 2 outside of the subject, and administering the vaccine to the subject |
| 06/14/2011 | US7960175 Process for producing human-origin immunocompetent cell |
| 06/14/2011 | US7960174 Hybridoma producing antibodies to Lawsonia intracellularis |
| 06/14/2011 | US7960163 Matriptase, a serine protease and its applications |
| 06/14/2011 | US7960143 Method for simultaneous production of multiple proteins; vectors and cells for use therein |
| 06/14/2011 | US7960142 Stabilized polypeptide compositions |
| 06/14/2011 | US7960128 TRP8, a transient receptor potential channel expressed in taste receptor cells |
| 06/14/2011 | US7960127 Using channel protein to identify inhibitors of bitter and/or sweet taste preception |
| 06/14/2011 | US7960126 Immunoregulation in cancer, chronic inflammatory and autoimmune diseases |
| 06/14/2011 | US7959929 isolated influenza virus that is capable of infecting a canid animal; genetic engineered influenza virus; vaccines for inducing an immune response against an influenza virus; veterinary medicine |
| 06/14/2011 | US7959925 Trimeric OX40-immunoglobulin fusion protein and methods of use |
| 06/14/2011 | US7959923 Method for treating cancer using anti-Wnt2 monoclonal antibodies and siRNA |
| 06/14/2011 | US7959919 Administering antibody, peptides, oligonucleotides, peptitomimetics, or small organic molecules having a binding region specific to factor B; antiinflammatory agent treating rheumatoid arthritis, anaphylactic shock, myasthenia gravis, asthma, Alzheimer's disease, cardiopulmonary bypass inflammation |
| 06/14/2011 | US7959918 Methods for treating vascular disease |
| 06/14/2011 | US7959915 Inhibitors of extracellular Hsp90 |
| 06/14/2011 | CA2475534C Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 06/14/2011 | CA2405084C Neutralizing immunogenic hev polypeptides |
| 06/14/2011 | CA2369622C Novel method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-egp-2 scfv fragment |
| 06/14/2011 | CA2324853C Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 06/14/2011 | CA2311646C Tsa305 gene |
| 06/14/2011 | CA2293829C Methods and compositions for galactosylated glycoproteins |
| 06/14/2011 | CA2271255C Affinity purification of polypeptide on protein a matrix |
| 06/14/2011 | CA2178212C Monoclonal antibodies specific for phf-tau, hybridomas secreting them, antigen recognition by these antibodies and their applications |
| 06/09/2011 | WO2011068261A1 Gene which enhances resistance to plant pathogens and use thereof |
| 06/09/2011 | WO2011068189A1 Method for detecting microorganisms belonging to mycoplasma pneumoniae and/or mycoplasma genitalium |
| 06/09/2011 | WO2011068143A1 Antibody against influenza virus subtype h5 and use thereof |
| 06/09/2011 | WO2011067711A2 Novel heparanase splice variant |
| 06/09/2011 | WO2011067616A1 Therapies for preventing or suppressing clostridium difficile infection |
| 06/09/2011 | WO2011067160A1 Von willebrand factor specific binding agents and uses thereof |
| 06/09/2011 | WO2011066783A1 Anti-cyr61 protein monoclonal antibodies and uses thereof |
| 06/09/2011 | WO2011066721A1 Antl-igf-ir antibodies and uses thereof |
| 06/09/2011 | WO2011066711A1 Specific antigen of clonorchis sinensis and uses thereof |
| 06/09/2011 | WO2011035101A4 Diagnostic tests for abnormal ovarian conditions |
| 06/09/2011 | WO2010060186A8 Antibodies that specifically block the biological activity of a tumor antigen |
| 06/09/2011 | US20110138496 Polypeptide for improving tolerance to iron deficiency in plants, and use thereof |
| 06/09/2011 | US20110138490 Desaturase and method for the production of polyunsaturated fatty acids in transgenic organisms |
| 06/09/2011 | US20110137406 Bioactive stents for type ii diabetics and methods for use thereof |
| 06/09/2011 | US20110137017 Cysteine engineered antibodies and conjugates |
| 06/09/2011 | US20110137016 Compositions and methods for the diagnosis and treatment of tumor |
| 06/09/2011 | US20110137015 Markers of XMRV Infection and Uses Thereof |
| 06/09/2011 | US20110137014 Super humanized antibodies |
| 06/09/2011 | US20110136743 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 06/09/2011 | US20110136695 Universal libraries for immunoglobulin |
| 06/09/2011 | US20110136689 Dual Expression Vector System for Antibody Expression in Bacterial and Mammalian Cells |
| 06/09/2011 | US20110136685 Method for determining a predisposition to basal cell carcinoma and for screening treatments thereof |
| 06/09/2011 | US20110136253 Irinotecan Immunoassay |
| 06/09/2011 | US20110136246 Novel oncogene nrf2 |
| 06/09/2011 | US20110136232 Anti-pyk2 antibodies |
| 06/09/2011 | US20110136201 Heterocycle-substituted xanthene dyes |
| 06/09/2011 | US20110136184 Method for producing alpha-1, 6-branched alpha-1, 4-glucans from sucrose |
| 06/09/2011 | US20110136183 Method for producing alpha-1, 6-branched alpha-1, 4-glucans from sucrose |
| 06/09/2011 | US20110136173 Novel Method for the Stabilization of Chimeric Immunoglobulins or Immunoglobulin Fragments, and Stabilized Anti-EGP-2 SCFV Fragment |
| 06/09/2011 | US20110136172 Mammalian cytokines; related reagents |
| 06/09/2011 | US20110136148 Monoclonal Antibodies Against GMF-B Antigens, and Uses Therefor |
| 06/09/2011 | US20110136121 Method for detecting cancer |
| 06/09/2011 | US20110135689 Vaccine, therapeutic composition and methods for treating or inhibiting francisella tularenis |
| 06/09/2011 | US20110135675 Melanoma associated peptide analogues and vaccines against melanoma |
| 06/09/2011 | US20110135673 Epitope protection assay |
| 06/09/2011 | US20110135672 Hla-g compositions and methods of use thereof |
| 06/09/2011 | US20110135667 Anti-cd79b antibodies and immunoconjugates and methods of use |
| 06/09/2011 | US20110135664 Monoclonal antibodies against the rgm a protein for use in the treatment of retinal nerve fiber layer degeneration |
| 06/09/2011 | US20110135663 Anti-igf-ir antibodies and uses thereof |
| 06/09/2011 | US20110135662 FUNCTION MODIFYING NAv 1.7 ANTIBODIES |
| 06/09/2011 | US20110135658 Vhz for diagnosis and treatment of cancers |
| 06/09/2011 | US20110135657 Human antigen binding proteins that bind beta-klotho, fgf receptors and complexes thereof |
| 06/09/2011 | US20110135654 Prostate cancer related gene styk1 |
| 06/09/2011 | US20110135653 Antibodies Against HER2 Truncated Variant CTF-611 |
| 06/09/2011 | US20110135648 Anti-neublastin antibodies and uses thereof |
| 06/09/2011 | US20110135647 Genes and polypeptides relating to breast cancers |
| 06/09/2011 | US20110135646 Genes of an Otitis Media Isolate of Nontypeable Haemophilus influenzae |
| 06/09/2011 | US20110135645 Human antibodies neutralizing human metapneumovirus |
| 06/09/2011 | US20110135643 Methods and compositions for prostate cancer immunotherapy |
| 06/09/2011 | US20110135642 Pharmaceutical Compositions Comprising Antibodies Binding To EBV (Ebstein-Barr Virus) Protein BARF1 |
| 06/09/2011 | US20110135639 B lymphocyte stimulator assays |
| 06/09/2011 | US20110135635 Anti-alpha2 integrin antibodies and their uses |
| 06/09/2011 | US20110135633 Chronic lymphocytic leukemia cell line |
| 06/09/2011 | US20110135630 Chemical modification of antibody fragments |
| 06/09/2011 | US20110135598 Methods to diagnose and immunize against the virus causing human merkel cell carcinoma |
| 06/09/2011 | US20110135597 Uses of Mammalian Cytokine; Related Reagents |
| 06/09/2011 | US20110135573 Metalloproteinase 9 and metalloproteinase 2 binding proteins |
| 06/09/2011 | US20110135570 Anti-Tumor Cell Antigen Antibody Therapeutics |
| 06/09/2011 | CA2782639A1 Therapies for preventing or suppressing clostridium difficile infection |
| 06/09/2011 | CA2782299A1 Methods for treating cancers comprising k-ras mutations |
| 06/08/2011 | EP2330213A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |